The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

PharMerica Corp

NYSE: PMC
Last

(U.S.) $20.55

Today's change-0.41 -1.96%
Updated December 22 11:58 AM EST. Delayed by at least 15 minutes.
 

PharMerica Corp

NYSE: PMC
Last

(U.S.) $20.55

Today's change-0.41 -1.96%
Updated December 22 11:58 AM EST. Delayed by at least 15 minutes.

PharMerica Corp down (U.S.)$0.41

PharMerica Corp is sharply lower today, dropping (U.S.)$0.41 or 1.96% to (U.S.)$20.55. Over the last five days, shares have gained 3.32%, but are down 4.42% for the last year to date. Shares have underperformed the S&P 500 by 16.06% during the last year.

Key company metrics

  • Open(U.S.) $20.96
  • Previous close(U.S.) $20.96
  • High(U.S.) $21.18
  • Low(U.S.) $20.00
  • Bid / Ask(U.S.) $20.55 / (U.S.) $20.59
  • YTD % change-4.42%
  • Volume222,650
  • Average volume (10-day)358,445
  • Average volume (1-month)318,359
  • Average volume (3-month)270,998
  • 52-week range(U.S.) $19.42 to (U.S.) $30.48
  • Beta1.18
  • Trailing P/E79.91×
  • P/E 1 year forward12.75×
  • Forward PEG1.28×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $0.26
Updated December 22 11:58 AM EST. Delayed by at least 15 minutes.
S&P TSX0.13%Sector:Non-Cyclical Consumer Goods & ServicesIndustry:Retail - Drugs
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2014Q2/2014Q1/2014Q4/2013
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201409/30/2014Jun 30, 201406/30/2014Mar 31, 201403/31/2014Dec 31, 201312/31/2013
Revenue470449452451
Total other revenue--------
Total revenue470449452451
Gross profit83828081
Total cost of revenue387367372369
Total operating expense457458442437
Selling / general / administrative56585758
Research & development--------
Depreciation / amortization5444
Interest expense (income), net operating--------
Unusual expense (income)92986
Other operating expenses, total--------
Operating income13-101014
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax11-12811
Income after tax9-1054
Income tax, total2-237
Net income9-1054
Total adjustments to net income--------
Net income before extra. items9-1054
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items9-1054
Inc. avail. to common incl. extra. items9-1054
Diluted net income9-1054
Dilution adjustment--0--0
Diluted weighted average shares31303030
Diluted EPS excluding extraordinary itemsvalue per share0.28-0.320.160.14
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share0.520.310.320.27